Ulcerative colitis: Prevention of relapse

Makoto Naganuma, Atsushi Sakuraba, Toshifumi Hibi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The clinical management of ulcerative colitis (UC) involves first treating the acute symptoms to induce remission, and then successfully maintaining it. Oral 5-aminosalicylic acids are safe and useful for maintaining remission in patients with UC. In terms of adherence, a once-daily form of 5-aminosalicylic acid is superior in maintaining remission as compared with split dosing. Patients at high risk of relapse may be candidates for treatment with thiopurines and/or biologics in the early stages of UC. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are effective for severe, steroid-refractory UC patients. It is suggested that these patients use thiopurines as their maintenance therapy once they achieve remission with calcineurin inhibitors. Recent studies have confirmed that biologics are effective for inducing clinical and endoscopic remission of UC, and thus they may improve long-term prognosis of UC.

Original languageEnglish
Pages (from-to)341-351
Number of pages11
JournalExpert Review of Gastroenterology and Hepatology
Volume7
Issue number4
DOIs
Publication statusPublished - 2013 May

Fingerprint

Secondary Prevention
Ulcerative Colitis
Mesalamine
Biological Products
Tacrolimus
Cyclosporine
Steroids
Recurrence
Therapeutics

Keywords

  • adherence
  • aminosalicylates
  • biologics
  • immunomodulators
  • prevention of relapse
  • ulcerative colitis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Ulcerative colitis : Prevention of relapse. / Naganuma, Makoto; Sakuraba, Atsushi; Hibi, Toshifumi.

In: Expert Review of Gastroenterology and Hepatology, Vol. 7, No. 4, 05.2013, p. 341-351.

Research output: Contribution to journalArticle

Naganuma, Makoto ; Sakuraba, Atsushi ; Hibi, Toshifumi. / Ulcerative colitis : Prevention of relapse. In: Expert Review of Gastroenterology and Hepatology. 2013 ; Vol. 7, No. 4. pp. 341-351.
@article{8554ebbfbefc4109a5b15c15516b4b59,
title = "Ulcerative colitis: Prevention of relapse",
abstract = "The clinical management of ulcerative colitis (UC) involves first treating the acute symptoms to induce remission, and then successfully maintaining it. Oral 5-aminosalicylic acids are safe and useful for maintaining remission in patients with UC. In terms of adherence, a once-daily form of 5-aminosalicylic acid is superior in maintaining remission as compared with split dosing. Patients at high risk of relapse may be candidates for treatment with thiopurines and/or biologics in the early stages of UC. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are effective for severe, steroid-refractory UC patients. It is suggested that these patients use thiopurines as their maintenance therapy once they achieve remission with calcineurin inhibitors. Recent studies have confirmed that biologics are effective for inducing clinical and endoscopic remission of UC, and thus they may improve long-term prognosis of UC.",
keywords = "adherence, aminosalicylates, biologics, immunomodulators, prevention of relapse, ulcerative colitis",
author = "Makoto Naganuma and Atsushi Sakuraba and Toshifumi Hibi",
year = "2013",
month = "5",
doi = "10.1586/egh.13.18",
language = "English",
volume = "7",
pages = "341--351",
journal = "Expert Review of Gastroenterology and Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Ulcerative colitis

T2 - Prevention of relapse

AU - Naganuma, Makoto

AU - Sakuraba, Atsushi

AU - Hibi, Toshifumi

PY - 2013/5

Y1 - 2013/5

N2 - The clinical management of ulcerative colitis (UC) involves first treating the acute symptoms to induce remission, and then successfully maintaining it. Oral 5-aminosalicylic acids are safe and useful for maintaining remission in patients with UC. In terms of adherence, a once-daily form of 5-aminosalicylic acid is superior in maintaining remission as compared with split dosing. Patients at high risk of relapse may be candidates for treatment with thiopurines and/or biologics in the early stages of UC. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are effective for severe, steroid-refractory UC patients. It is suggested that these patients use thiopurines as their maintenance therapy once they achieve remission with calcineurin inhibitors. Recent studies have confirmed that biologics are effective for inducing clinical and endoscopic remission of UC, and thus they may improve long-term prognosis of UC.

AB - The clinical management of ulcerative colitis (UC) involves first treating the acute symptoms to induce remission, and then successfully maintaining it. Oral 5-aminosalicylic acids are safe and useful for maintaining remission in patients with UC. In terms of adherence, a once-daily form of 5-aminosalicylic acid is superior in maintaining remission as compared with split dosing. Patients at high risk of relapse may be candidates for treatment with thiopurines and/or biologics in the early stages of UC. Calcineurin inhibitors, such as cyclosporine and tacrolimus, are effective for severe, steroid-refractory UC patients. It is suggested that these patients use thiopurines as their maintenance therapy once they achieve remission with calcineurin inhibitors. Recent studies have confirmed that biologics are effective for inducing clinical and endoscopic remission of UC, and thus they may improve long-term prognosis of UC.

KW - adherence

KW - aminosalicylates

KW - biologics

KW - immunomodulators

KW - prevention of relapse

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84877257397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877257397&partnerID=8YFLogxK

U2 - 10.1586/egh.13.18

DO - 10.1586/egh.13.18

M3 - Article

C2 - 23639092

AN - SCOPUS:84877257397

VL - 7

SP - 341

EP - 351

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

SN - 1747-4124

IS - 4

ER -